136 related articles for article (PubMed ID: 23341209)
41. Synthesis and biological evaluation of disubstituted amidoxanthones as potential telomeric G-quadruplex DNA-binding and apoptosis-inducing agents.
Shen R; Chen Y; Li Z; Qi H; Wang Y
Bioorg Med Chem; 2016 Feb; 24(4):619-26. PubMed ID: 26740156
[TBL] [Abstract][Full Text] [Related]
42. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.
Qin YJ; Li YJ; Jiang AQ; Yang MR; Zhu QZ; Dong H; Zhu HL
Eur J Med Chem; 2015 Apr; 94():447-57. PubMed ID: 25828827
[TBL] [Abstract][Full Text] [Related]
43. Design, synthesis and cytotoxicity of novel 2-arylvinyl-4-aminoquinoline derivatives.
Jiang N; Zhai X; Chen Z; Liang C; Sun C; Han J; Gong P
Chem Pharm Bull (Tokyo); 2012; 60(5):659-64. PubMed ID: 22689404
[TBL] [Abstract][Full Text] [Related]
44. Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7.
Castanheiro RA; Pinto MM; Silva AM; Cravo SM; Gales L; Damas AM; Nazareth N; Nascimento MS; Eaton G
Bioorg Med Chem; 2007 Sep; 15(18):6080-8. PubMed ID: 17614292
[TBL] [Abstract][Full Text] [Related]
45. Design, synthesis and biological evaluation of heterocyclic azoles derivatives containing pyrazine moiety as potential telomerase inhibitors.
Zhang YB; Wang XL; Liu W; Yang YS; Tang JF; Zhu HL
Bioorg Med Chem; 2012 Nov; 20(21):6356-65. PubMed ID: 23018096
[TBL] [Abstract][Full Text] [Related]
46. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
47. Antioxidant xanthone derivatives induce cell cycle arrest and apoptosis and enhance cell death induced by cisplatin in NTUB1 cells associated with ROS.
Cheng JH; Huang AM; Hour TC; Yang SC; Pu YS; Lin CN
Eur J Med Chem; 2011 Apr; 46(4):1222-31. PubMed ID: 21345544
[TBL] [Abstract][Full Text] [Related]
48. An oxidative analogue of gambogic acid-induced apoptosis of human hepatocellular carcinoma cell line HepG2 is involved in its anticancer activity in vitro.
Mu R; Lu N; Wang J; Yin Y; Ding Y; Zhang X; Gui H; Sun Q; Duan H; Zhang L; Zhang Y; Ke X; Guo Q
Eur J Cancer Prev; 2010 Jan; 19(1):61-7. PubMed ID: 19934761
[TBL] [Abstract][Full Text] [Related]
49. Synthesis of novel heterocyclic ring-fused 18β-glycyrrhetinic acid derivatives with antitumor and antimetastatic activity.
Gao C; Dai FJ; Cui HW; Peng SH; He Y; Wang X; Yi ZF; Qiu WW
Chem Biol Drug Des; 2014 Aug; 84(2):223-33. PubMed ID: 24612785
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and cytotoxicity of 3,4-disubstituted-5-(3,4,5-trimethoxyphenyl)-4H-1,2,4-triazoles and novel 5,6-dihydro-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives bearing 3,4,5-trimethoxyphenyl moiety.
Zhao PL; Duan AN; Zou M; Yang HK; You WW; Wu SG
Bioorg Med Chem Lett; 2012 Jul; 22(13):4471-4. PubMed ID: 22647723
[TBL] [Abstract][Full Text] [Related]
51. Novel rotundic acid derivatives: synthesis, structural characterization and in vitro antitumor activity.
Chen Y; He YF; Nan ML; Sun WY; Hu J; Cui A; Li F; Wang F
Int J Mol Med; 2013 Feb; 31(2):353-60. PubMed ID: 23233042
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and in vitro cytotoxic evaluation of some thiazolylbenzimidazole derivatives.
Luo Y; Xiao F; Qian S; Lu W; Yang B
Eur J Med Chem; 2011 Jan; 46(1):417-22. PubMed ID: 21115212
[TBL] [Abstract][Full Text] [Related]
53. Synthesis of novel benzoxanthone analogues as non-Camptothecin topoisomerase I inhibitors.
Cheng P; Zhu L; Guo W; Liu W; Yao J; Dong G; Zhang Y; Zhuang C; Sheng C; Miao Z; Zhang W
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):437-42. PubMed ID: 21770860
[TBL] [Abstract][Full Text] [Related]
54. Novel Natural Product-like Caged Xanthones Bearing a Carbamate Moiety Exhibit Antitumor Potency and Anti-Angiogenesis Activity In vivo.
Xu X; Wu Y; Hu M; Li X; Bao Q; Bian J; You Q; Zhang X
Sci Rep; 2016 Oct; 6():35771. PubMed ID: 27767192
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents.
Hua SX; Huang RZ; Ye MY; Pan YM; Yao GY; Zhang Y; Wang HS
Eur J Med Chem; 2015 May; 95():435-52. PubMed ID: 25841199
[TBL] [Abstract][Full Text] [Related]
56. Synthesis and antitumor activity of dehydroepiandrosterone derivatives on Es-2, A549, and HepG2 cells in vitro.
Liu XK; Ye BJ; Wu Y; Nan JX; Lin ZH; Piao HR
Chem Biol Drug Des; 2012 Apr; 79(4):523-9. PubMed ID: 22181987
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and in vitro antitumor activities of lupeol dicarboxylic acid monoester derivatives.
Li W; Hao J; Xiao Y
Arch Pharm Res; 2013 Dec; 36(12):1447-53. PubMed ID: 23700293
[TBL] [Abstract][Full Text] [Related]
58. Synthesis of indazole based diarylurea derivatives and their antiproliferative activity against tumor cell lines.
Zhao CR; Wang RQ; Li G; Xue XX; Sun CJ; Qu XJ; Li WB
Bioorg Med Chem Lett; 2013 Apr; 23(7):1989-92. PubMed ID: 23454017
[TBL] [Abstract][Full Text] [Related]
59. Synthesis, biological evaluation and molecular modeling of 1,3,4-thiadiazol-2-amide derivatives as novel antitubulin agents.
Li YJ; Qin YJ; Makawana JA; Wang YT; Zhang YQ; Zhang YL; Yang MR; Jiang AQ; Zhu HL
Bioorg Med Chem; 2014 Aug; 22(15):4312-22. PubMed ID: 24909678
[TBL] [Abstract][Full Text] [Related]
60. Design, synthesis and biological evaluations of chirally pure 1,2,3,4-tertrahydroisoquinoline analogs as anti-cancer agents.
Ramanivas T; Sushma B; Nayak VL; Chandra Shekar K; Srivastava AK
Eur J Med Chem; 2015 Mar; 92():608-18. PubMed ID: 25615796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
